ResearcherKyushu UniversityActive in the last 2 years
Masataka Hayashi
Matched on ORCID iD 0000-0002-1823-0205; OpenAlex author ID A5000759944. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2023: 2 papers · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper
Papers 8
- Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
- Personalizing CA125 Levels Using Tumor Marker Variants: A Case-Control Analysis of Diagnostic Performance for Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-25-1050↗
- Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cance… Co-author DOI 10.1158/0008-5472.can-24-0830↗
- Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. Co-author DOI 10.1186/s13046-024-03060-5↗
- Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03178-6↗
- [Microbiome in the Therapy for the Pancreatic Cancer]. First author PMID 39009514↗
- Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-023-05591-2↗
- Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Co-author DOI 10.1111/cas.15901↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kohei Nakata · 6 shared papers, 2023–2024 · strength 1.03
- Paper [Microbiome in the Therapy for the Pancreatic Cancer]. PMID 39009514↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Naoki Ikenaga · 6 shared papers, 2023–2024 · strength 1.03
- Paper [Microbiome in the Therapy for the Pancreatic Cancer]. PMID 39009514↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Chika Iwamoto · 5 shared papers, 2023–2024 · strength 0.87
- Paper [Microbiome in the Therapy for the Pancreatic Cancer]. PMID 39009514↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Kenoki Ohuchida · 5 shared papers, 2023–2024 · strength 0.87
- Paper [Microbiome in the Therapy for the Pancreatic Cancer]. PMID 39009514↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Masafumi Nakamura · 5 shared papers, 2023–2024 · strength 0.86
- Paper [Microbiome in the Therapy for the Pancreatic Cancer]. PMID 39009514↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Yoshinao Oda · 5 shared papers, 2023–2024 · strength 0.79
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Toshiya Abe · 5 shared papers, 2023–2024 · strength 0.79
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Koki Oyama · 4 shared papers, 2023–2024 · strength 0.63
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Haizhen Luo · 4 shared papers, 2023–2024 · strength 0.63
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Pingshan Zhong · 4 shared papers, 2023–2024 · strength 0.63
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Noboru Ideno · 3 shared papers, 2023–2024 · strength 0.48
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Michael Goggins · 2 shared papers, 2025–2026 · strength 0.47
- Paper Personalizing CA125 Levels Using Tumor Marker Variants: A Case-Control Analysis of Diagnostic Performance for Pancreati… DOI 10.1158/1055-9965.epi-25-1050↗
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Chikanori Tsutsumi · 2 shared papers, 2024 · strength 0.32
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Kazuhiro Koikawa · 2 shared papers, 2024 · strength 0.32
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Takashi Morisaki · 2 shared papers, 2024 · strength 0.32
- Paper Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer… DOI 10.1186/s13046-024-03060-5↗
- Paper Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint … DOI 10.1158/0008-5472.can-24-0830↗
- Jin Peng He · 1 shared paper, 2025 · strength 0.25
- Marcia Irene Canto · 1 shared paper, 2025 · strength 0.25
- Amanda L. Blackford · 1 shared paper, 2025 · strength 0.25
- Yuto Hozaka · 1 shared paper, 2025 · strength 0.25
- Takeichi Yoshida · 1 shared paper, 2025 · strength 0.25
- Katsuya Hirose · 1 shared paper, 2025 · strength 0.25
- Elham Afghani · 1 shared paper, 2025 · strength 0.25
- Suyu Liu · 1 shared paper, 2026 · strength 0.23
- Subrata Sen · 1 shared paper, 2026 · strength 0.23
- Seetharaman Balasenthil · 1 shared paper, 2026 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.